Daniela Finke

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 4

Top Topics

Immune Response

Acute Lymphoblastic Leukemia

Top Venues

Nature communications

Mucosal immunology

Nature immunology

This page only lists publications with an associated author ORCID identifier.

Publications

Jerome Egli, Stefan Heiler, Felix Weber, Guido Steiner, Timo Schwandt, Katharine Bray-French, Christian Klein, Sebastian Fenn, Gregor P Lotz, Eugenia Opolka-Hoffmann, Thomas E Kraft, Laetitia Petersen, Rebecca Moser, Jonathan DeGeer, Michel Siegel, Daniela Finke, Juliana Bessa, Antonio Iglesias
Enhanced immunogenic potential of cancer immunotherapy antibodies in human IgG1 transgenic mice. mAbs 14 (1) (2022)
Claudia Teufel, Edit Horvath, Annick Peter, Caner Ercan, Salvatore Piscuoglio, Michael N Hall, Daniela Finke, Frank M Lehmann
mTOR signaling mediates ILC3-driven immunopathology. Mucosal immunology 14 (6) (2021)
Christina Stehle, Timo Rückert, Remi Fiancette, Dominika W Gajdasik, Claire Willis, Carolin Ulbricht, Pawel Durek, Mir-Farzin Mashreghi, Daniela Finke, Anja Erika Hauser, David R Withers, Hyun-Dong Chang, Jakob Zimmermann, Chiara Romagnani
T-bet and RORα control lymph node formation by regulating embryonic innate lymphoid cell differentiation. Nature immunology 22 (10) (2021)
Frank Michael Lehmann, Nicole von Burg, Robert Ivanek, Claudia Teufel, Edit Horvath, Annick Peter, Gleb Turchinovich, Daniel Staehli, Tobias Eichlisberger, Mercedes Gomez de Agüero, Mairene Coto-Llerena, Michaela Prchal-Murphy, Veronika Sexl, Mohamed Bentires-Alj, Christoph Müller, Daniela Finke
Microbiota-induced tissue signals regulate ILC3-mediated antigen presentation. Nature communications 11 (1) (2020)